These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 9007203

  • 1. Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albumins.
    Groenink M, Swart PJ, Broersen S, Kuipers M, Meijer DK, Schuitemaker H.
    AIDS Res Hum Retroviruses; 1997 Jan 20; 13(2):179-85. PubMed ID: 9007203
    [Abstract] [Full Text] [Related]

  • 2. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK.
    Mol Pharmacol; 1993 Nov 20; 44(5):1003-7. PubMed ID: 7902528
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice.
    Kuipers ME, Swart PJ, Schutten M, Smit C, Proost JH, Osterhaus AD, Meijer DK.
    Antiviral Res; 1997 Jan 20; 33(2):99-108. PubMed ID: 9021051
    [Abstract] [Full Text] [Related]

  • 5. Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT.
    Kuipers ME, Swart PJ, Witvrouw M, Esté JA, Reymen D, De Clercq E, Meijer DK.
    J Drug Target; 1999 Jan 20; 6(5):323-35. PubMed ID: 10342381
    [Abstract] [Full Text] [Related]

  • 6. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.
    Beljaars L, Floris R, Berkhout B, Smit C, Meijer DK, Molema G.
    Biochem Pharmacol; 2002 May 01; 63(9):1663-73. PubMed ID: 12007569
    [Abstract] [Full Text] [Related]

  • 7. The in vitro anti-HIV efficacy of negatively charged human serum albumin is antagonized by heparin.
    Swart PJ, Sun CS, Kuipers ME, Asuncion C, Josephs S, Smit C, Meijer DK.
    AIDS Res Hum Retroviruses; 1997 May 20; 13(8):677-83. PubMed ID: 9168236
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of anti-HIV activity of succinylated human serum albumin.
    Kuipers ME, vd Berg M, Swart PJ, Laman JD, Meijer DK, Koppelman MH, Huisman H.
    Biochem Pharmacol; 1999 Apr 15; 57(8):889-98. PubMed ID: 10086322
    [Abstract] [Full Text] [Related]

  • 9. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.
    Kamps JA, Swart PJ, Morselt HW, Pauwels R, De Béthune MP, De Clercq E, Meijer DK, Scherphof GL.
    Biochim Biophys Acta; 1996 Jan 31; 1278(2):183-90. PubMed ID: 8593275
    [Abstract] [Full Text] [Related]

  • 10. Replicative characteristics of primary isolates of the human immunodeficiency virus type 1 in peripheral blood mononuclear cells, primary macrophages and CD4+ transformed T-cell lines.
    Jolly PE.
    Cell Mol Biol (Noisy-le-grand); 1997 Nov 31; 43(7):1057-65. PubMed ID: 9449539
    [Abstract] [Full Text] [Related]

  • 11. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.
    Swart PJ, Beljaars E, Smit C, Pasma A, Schuitemaker H, Meijer DK.
    J Drug Target; 1996 Nov 31; 4(2):109-16. PubMed ID: 8894971
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of influenza virus fusion by polyanionic proteins.
    Schoen P, Corver J, Meijer DK, Wilschut J, Swart PJ.
    Biochem Pharmacol; 1997 Apr 04; 53(7):995-1003. PubMed ID: 9174113
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania.
    Easterbrook MD, Levy MH, Gomez AM, Turco SJ, Epand RM, Rosenthal KL.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec 15; 10(5):496-505. PubMed ID: 8548328
    [Abstract] [Full Text] [Related]

  • 14. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo.
    Fouchier RA, Meyaard L, Brouwer M, Hovenkamp E, Schuitemaker H.
    Virology; 1996 May 01; 219(1):87-95. PubMed ID: 8623557
    [Abstract] [Full Text] [Related]

  • 15. 3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry.
    Li L, Qiu J, Lu L, An S, Qiao P, Jiang S, Liu S.
    J Antimicrob Chemother; 2013 Mar 01; 68(3):573-6. PubMed ID: 23221626
    [Abstract] [Full Text] [Related]

  • 16. Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
    Forte SE, Byron KS, Sullivan JL, Somasundaran M.
    AIDS Res Hum Retroviruses; 1994 Dec 01; 10(12):1613-8. PubMed ID: 7888220
    [Abstract] [Full Text] [Related]

  • 17. Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages.
    Javan CM, Gooderham NJ, Edwards RJ, Davies DS, Shaunak S.
    AIDS Res Hum Retroviruses; 1997 Jul 01; 13(10):875-80. PubMed ID: 9197381
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA.
    Hum Gene Ther; 1999 Jun 10; 10(9):1453-67. PubMed ID: 10395371
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.